1.Siegel, R., et al., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 2011. 61(4): p. 212–36.
2.Kyrgiou M, S. M., Invasive cancer of the cervix. Obstetrics, Gynaecology and Reproductive Medicine, 2010. 20(5): p. 147–154.
3.Chen WQ, Z. R., Zhang SW, Report of cancer incidence and mortality in China, 2012. China Cancer, 2016. 2(7): p. 61.
4.Chen WQ, Z. R., Zhang SW, Report of cancer incidence and mortality in China, 2013. China Cancer, 2016. 27(1): p. 1–8.
5.Walboomers, J. M., et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999. 189(1): p. 12–9.
6.Humans, I. W. G.o.t.E.o.C. R.t., Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum, 2012. 100(Pt E): p. 1–538.
7.Schiffman, M., et al., Human papillomavirus and cervical cancer. Lancet, 2007. 370(9590): p. 890–907.
8.Smith, J. S., et al., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 2007. 121(3): p. 621–32.
9.Smith, J. S., et al., Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health, 2008. 43(4 Suppl): p. S5–25, S25 e1–41.
10.Clifford, G. M., et al., Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 2003. 88(1): p. 63–73.
11.Wu, R. F., et al., Human papillomavirus infection in women in Shenzhen City, People’s Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer, 2007. 121(6): p. 1306–11.
12.Liu, X. X., et al., Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study. BMC Infect Dis, 2014. 14: p. 708.
13.Li, Z., et al., Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci Rep, 2016. 6: p. 21039.
14.Jing, L., et al., Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis, 2014. 41(12): p. 732–8.
15.Li, L. K., et al., Human papillomavirus infection in Shenyang City, People’s Republic of China: A population-based study. Br J Cancer, 2006. 95(11): p. 1593–7.
16.Zhi, Y. F., et al., Prevalence and genotype distribution of human papillomavirus in women in the Henan Province. Genet Mol Res, 2015. 14(2): p. 5452–61.
17.Dickson, E. L., et al., Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer, 2013. 23(7): p. 1295–302.
18.Wang, L., et al., Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer patients in Hunan province, central south China. J Med Virol, 2015. 87(3): p. 516–21.
19.Dai, M., et al., Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer, 2006. 95(1): p. 96–101.
20.Herrero, R., et al., Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst, 2000. 92(6): p. 464–74.
21.Sherman, M. E., et al., Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst, 2003. 95(1): p. 46–52.
22.Lawson, H. W., Practice Bulletin No. 157: Cervical Cancer Screening and Prevention. Obstet Gynecol, 2016. 127(1): p. e1-e20.
23.Saslow, D., et al., American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol, 2012. 137(4): p. 516–42.